UPDATE: Deal reached on bipartisan $8.3B bill to battle coronavirus

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Capitol Hill negotiators have reached agreement on an $8.3 billion measure to battle the coronavirus outbreak that’s spreading and threatening a major shock to the economy and disruptions to everyday life in the United States.

The House will vote on the deal later Wednesday and Senate leaders are pressing for a vote in that chamber by the end of the week.

The legislation came together unusually quickly, a rarity in a deeply polarized Washington. It triples the $2.5 billion plan unveiled by President Donald Trump just last week.

Trump, however, is sure to sign the measure, which has the blessing of top Republicans like Senate Majority Leader Mitch McConnell, R-Ky., and top House Republican Kevin McCarthy of California.

The agreement came together after House Speaker Nancy Pelosi, D-Calif., dropped a demand, opposed by the drug industry, to guarantee that any vaccines and drug treatments developed with government-backed research—but manufactured by drug companies—be offered at “affordable” prices.

Instead, the agreement provides $300 million for the government to purchase and distribute such drugs to those who need it at “fair and reasonable” prices—which is the standard applied in earlier outbreaks like the 2009 H1N1 flu outbreak.

The bipartisan legislation includes: $350 million to aggressively go after the virus in “hot spots” like Washington state; $500 million to buy drugs, masks, and other medical supplies for states, local governments and hospitals; $1 billion to reimburse state and local governments for costs incurred in battling the outbreak; and $300 million for the Centers for Disease Control’s rapid response fund.

More than $800 million would fund research into a vaccine, improved tests, and drugs to treat infected people. Another $1.3 billion would be used to help fight the virus overseas.

The agreement comes as the outbreak in the U.S. appears increasingly likely to affect workers who are instructed to stay home, immigrants who may fear seeking treatment because they are in the U.S. illegally, and the potential rapid spread among homeless people. Widespread school closures are possible as well.

Vice President Mike Pence, who is coordinating the administration’s response, is returning to Capitol on Wednesday afternoon to separately brief House Democrats and Republicans.

Also Wednesday, top congressional leaders are meeting to discuss what additional steps may be needed to ensure the safety of the Capitol complex — for lawmakers and staff, as well as the annual influx of visitors this spring.

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In